Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma.

Strizova Z, Bartunkova J, Smrz D.

Cancer Immunol Immunother. 2019 Nov;68(11):1831-1838. doi: 10.1007/s00262-019-02359-z. Epub 2019 Jun 20. Review.


NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma.

Strizova Z, Taborska P, Stakheev D, Partlová S, Havlova K, Vesely S, Bartunkova J, Smrz D.

Urol Oncol. 2019 Jul;37(7):503-509. doi: 10.1016/j.urolonc.2019.03.014. Epub 2019 Apr 26.


Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production.

Tobío A, Bandara G, Morris DA, Kim DK, O'Connell MP, Komarow HD, Carter MC, Smrz D, Metcalfe DD, Olivera A.

Haematologica. 2020 Jan;105(1):124-135. doi: 10.3324/haematol.2018.212126. Epub 2019 Apr 4.


The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.

Stakheev D, Taborska P, Strizova Z, Podrazil M, Bartunkova J, Smrz D.

Sci Rep. 2019 Mar 18;9(1):4761. doi: 10.1038/s41598-019-41182-5.


Simultaneous in vitro generation of human CD34+-derived dendritic cells and mast cells from non-mobilized peripheral blood mononuclear cells.

Taborska P, Bartunkova J, Smrz D.

J Immunol Methods. 2018 Jul;458:63-73. doi: 10.1016/j.jim.2018.04.005. Epub 2018 Apr 21.


Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.

Taborska P, Stakheev D, Strizova Z, Vavrova K, Podrazil M, Bartunkova J, Smrz D.

Med Oncol. 2017 Sep 2;34(10):173. doi: 10.1007/s12032-017-1035-x.


Flow cytometry-based monitoring of mast cell activation.

Cruse G, Gilfillan AM, Smrz D.

Methods Mol Biol. 2015;1220:365-79. doi: 10.1007/978-1-4939-1568-2_23.


Rictor negatively regulates high-affinity receptors for IgE-induced mast cell degranulation.

Smrz D, Cruse G, Beaven MA, Kirshenbaum A, Metcalfe DD, Gilfillan AM.

J Immunol. 2014 Dec 15;193(12):5924-32. doi: 10.4049/jimmunol.1303495. Epub 2014 Nov 5.


Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells.

Smrž D, Bandara G, Beaven MA, Metcalfe DD, Gilfillan AM.

Eur J Immunol. 2013 Jul;43(7):1873-82. doi: 10.1002/eji.201243214. Epub 2013 Jun 4.


Cross-talk between tetraspanin CD9 and transmembrane adaptor protein non-T cell activation linker (NTAL) in mast cell activation and chemotaxis.

Hálová I, Dráberová L, Bambousková M, Machyna M, Stegurová L, Smrz D, Dráber P.

J Biol Chem. 2013 Apr 5;288(14):9801-14. doi: 10.1074/jbc.M112.449231. Epub 2013 Feb 26.


A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.

Smrž D, Bandara G, Zhang S, Mock BA, Beaven MA, Metcalfe DD, Gilfillan AM.

J Immunol Methods. 2013 Apr 30;390(1-2):52-62. doi: 10.1016/j.jim.2013.01.008. Epub 2013 Jan 25.


IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

Jung MY, Smrž D, Desai A, Bandara G, Ito T, Iwaki S, Kang JH, Andrade MV, Hilderbrand SC, Brown JM, Beaven MA, Metcalfe DD, Gilfillan AM.

J Immunol. 2013 Jan 15;190(2):531-8. doi: 10.4049/jimmunol.1201576. Epub 2012 Dec 17.


Stem cell factor programs the mast cell activation phenotype.

Ito T, Smrž D, Jung MY, Bandara G, Desai A, Smržová Š, Kuehn HS, Beaven MA, Metcalfe DD, Gilfillan AM.

J Immunol. 2012 Jun 1;188(11):5428-37. doi: 10.4049/jimmunol.1103366. Epub 2012 Apr 23.


Providing the TORC for cell cycle progression in neoplastic mast cells.

Smrž D, Wilson TM, Metcalfe DD, Gilfillan AM.

Cell Cycle. 2012 Jan 15;11(2):210-1. doi: 10.4161/cc.11.2.18976. Epub 2012 Jan 15. No abstract available.


mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.

Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM.

Blood. 2011 Dec 22;118(26):6803-13. doi: 10.1182/blood-2011-06-359984. Epub 2011 Nov 3.


Glycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasis.

Rådinger M, Smrž D, Metcalfe DD, Gilfillan AM.

J Immunol. 2011 Dec 1;187(11):5587-95. doi: 10.4049/jimmunol.1101257. Epub 2011 Oct 28.


TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release.

Smrz D, Iwaki S, McVicar DW, Metcalfe DD, Gilfillan AM.

Eur J Immunol. 2010 Dec;40(12):3557-69. doi: 10.1002/eji.201040573. Epub 2010 Nov 11.


Engagement of phospholipid scramblase 1 in activated cells: implication for phosphatidylserine externalization and exocytosis.

Smrz D, Lebduska P, Dráberová L, Korb J, Dráber P.

J Biol Chem. 2008 Apr 18;283(16):10904-18. doi: 10.1074/jbc.M710386200. Epub 2008 Feb 16.


Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins.

Smrz D, Dráberová L, Dráber P.

J Biol Chem. 2007 Apr 6;282(14):10487-97. Epub 2007 Feb 5.


The murine endogenous retrovirus MIA14 encodes an active aspartic proteinase that is functionally similar to proteinases from D-type retroviruses.

Strísovský K, Smrz D, Fehrmann F, Kräusslich HG, Konvalinka J.

Arch Biochem Biophys. 2002 Feb 15;398(2):261-8.


Supplemental Content

Support Center